Aurinia Pharmaceuticals Inc.

TSX (CAD): Aurinia Pharmaceuticals Inc. (AUP)

Last Price

16.76

Today's Change

-0.61 (3.51%)

Day's Change

16.41 - 17.46

Trading Volume

4,609,908

Profile
AUP

Exchange:  Toronto Stock Exchange Toronto Stock Exchange

Currency:  CAD CAD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Peter Greenleaf Mr. Peter Greenleaf

Full Time Employees:  294 294

IPO Date:  2000-09-19 2000-09-19

CIK: 

ISIN: 

CUSIP: 

Beta:  0.28 0.28

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.

Address

1203-4464 Markham St,
Victoria, BRITISH COLUMBIA V8Z 7X8, CA

12507084272

http://www.auriniapharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment